Crossref
Lapatinib in the treatment of advanced HER2-positive breast cancer
OncoReview · 2017
DOI: 10.24292/01.or.170817 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoReview, 2017. Verfasst von Małgorzata Kuc-Rajca und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kuc-Rajca, M., & Walaszkowska-Czyż, A. (2017). Lapatinib in the treatment of advanced HER2-positive breast cancer. OncoReview. https://doi.org/10.24292/01.or.170817
Vancouver
Kuc-Rajca M, Walaszkowska-Czyż A. Lapatinib in the treatment of advanced HER2-positive breast cancer. OncoReview. 2017. doi:10.24292/01.or.170817
BibTeX
@article{KucRajca2017,
author = {Kuc-Rajca, Małgorzata and Walaszkowska-Czyż, Anna},
title = {Lapatinib in the treatment of advanced HER2-positive breast cancer},
journal = {OncoReview},
year = {2017},
doi = {10.24292/01.or.170817}
}
EUVIMED